Aim
The aim of our study was to determine the accuracy of endorectal ultrasonography (ERUS) in staging locally advanced rectal
cancer after preoperative neoadjuvant chemoradiation and to point out the most common reasons for false interpretation.
Methods
Forty-four patients with locally advanced rectal cancer received neoadjuvant chemoradiation followed by radical surgery. Restaging
was done 1–2 weeks before surgery and the results of ERUS staging were compared with histopathology findings of the resected
specimen.
Results
The accuracy of ERUS for T stage after chemoradiation was 75% (33/44). Overstaging occurred in 18% (8/44) of patients, and
7% (3/44) were understaged. The majority of overstaging occurred in patients with ERUS T3 tumors, eventually found to have
pathological pT0–pT2 staging. Five patients (11.4%) had complete histology regression and only one of these patients was staged
correctly while others were overstaged. In the detection of perirectal lymph node metastases, ERUS was accurate in 68% of
patients (30/44). Twenty percent (9/44) of patients were overstaged and 11% were (5/44) understaged.
Conclusions
ERUS provides a good accuracy rate for staging rectal cancer after neoadjuvant chemoradiation. However, it is insuficient
in detection of complete pathological response.
Keywords Rectal cancer - Staging - Endorectal ultrasound - Preoperative chemoradiation